Oncotarget

Meta-Analysis:

Comparison of 18FDG PET/PET-CT and bone scintigraphy for detecting bone metastases in patients with nasopharyngeal cancer: a meta-analysis

Chuanhui Xu, Ruiming Zhang _, Huanlei Zhang and Zhenyan Zhang

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:59740-59747. https://doi.org/10.18632/oncotarget.20026

Metrics: PDF 1102 views  |   HTML 1516 views  |   ?  


Abstract

Chuanhui Xu1,*, Ruiming Zhang1,*, Huanlei Zhang1 and Zhenyan Zhang1

1Department of Radiology, Yidu Central Hospital of Weifang, Qingzhou 262500, Shandong, PR China

*These authors contributed equally to this work as first author

Correspondence to:

Ruiming Zhang, email: zhangruimingsd@sina.com

Keywords: PET, bone scintigraphy, nasopharyngeal cancer, staging, bone metastases

Received: July 04, 2017     Accepted: July 26, 2017     Published: August 07, 2017

ABSTRACT

Objective: We performed a meta-analysis to compare the diagnostic efficacy of 18FDG PET/PET-CT and bone scintigraphy (BS) for diagnosing bone metastatic cancers in nasopharyngeal cancer patients.

Results: 6 studies (1238 patients) fulfilled the inclusion criteria. The pooled sensitivities for 18FDG PET/PET-CT and BS were 0.81 (95% confidence interval [CI] = 0.70 to 0.98) and 0.39 (95% CI = 0.26 to 0.54), specificities were 0.99 (95% CI = 0.98 to 0.99) and 0.98 (95% CI = 0.96 to 0.99), and the areas under curve were 0.98 (95% CI = 0.97 to 0.99) and 0.84 (95% CI = 0.81 to 0.87).

Materials and Methods: Several databases were searched for all available articles. We calculated the sensitivities, specificities, diagnostic odds ratios, likelihood ratios, and area under summary receiver operating characteristic curves for 18FDG PET/PET-CT and BS, respectively.

Conclusions: 18FDG PET/PET-CT is superior to BS for diagnosing bone metastases in nasopharyngeal cancer patients.18FDG PET/PET-CT may enhance the diagnosis of bone metastases and provide more accurate information for the optimal management of nasopharyngeal cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 20026